At a glance
- Originator Nonindustrial source
- Class Cytostatic antibiotics; Sesquiterpenes; Small molecules
- Mechanism of Action DNA synthesis inhibitors; Protein synthesis inhibitors; RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 01 Jul 1998 No-Development-Reported for Cancer in Germany (Unknown route)
- 01 Jul 1998 No-Development-Reported for Cancer in Sweden (Unknown route)
- 15 Dec 1996 Preclinical development for Cancer in Germany (Unknown route)